首頁(yè) > 權(quán)威專家 > 浜幸寬教授

浜幸寬

現(xiàn)任: 江戶川綜合醫(yī)院放射科主任 日本托姆刀治療引領(lǐng)者

擅長(zhǎng)疾病:

預(yù)約掛號(hào)

浜幸寬醫(yī)師早在2009年就成為了江戶川綜合醫(yī)院的放射科主任,在放射腫瘤學(xué),分子成像方面有著豐富的經(jīng)驗(yàn),被業(yè)內(nèi)稱為“日本托姆刀治療引領(lǐng)者”,被評(píng)為走在的前沿的16位名醫(yī)之一。厚樸方舟與浜幸寬醫(yī)師保持長(zhǎng)期深度合作,為大量國(guó)內(nèi)患者提供了更權(quán)威的醫(yī)療解決方案。

浜幸寬醫(yī)師被評(píng)為走在前沿的16位名醫(yī)之一

浜幸寬醫(yī)師就任的江戶川綜合醫(yī)院是世界上較早引進(jìn)三臺(tái)托姆刀(tomotherapy 螺旋斷層放射治療系統(tǒng))的,也是目前少數(shù)同時(shí)擁有三臺(tái)托姆刀的綜合醫(yī)院,托姆刀放射治療實(shí)例僅 2013 年就多達(dá) 17,741 例,之后治療實(shí)績(jī)更是穩(wěn)步提升,2014年達(dá)到22149件,2015年26128件、2016年23810件。

浜幸寬醫(yī)師帶領(lǐng)的放射科獲得了調(diào)強(qiáng)放射療法(IMRT)的認(rèn)證,擁有可靠的技術(shù)和豐富的經(jīng)驗(yàn),可以為患者提供日本先進(jìn)的放療。如使用無(wú)曝光MRI作為圖像評(píng)估的基礎(chǔ)(MRI不具有放射線暴露且圖像處理準(zhǔn)確),同時(shí)該科室是世界上唯一在同一設(shè)施中同時(shí)安裝了低磁場(chǎng)設(shè)備和高磁場(chǎng)設(shè)備(MRidian)的醫(yī)療機(jī)構(gòu),可以為患者提供低磁場(chǎng)設(shè)備和高磁場(chǎng)設(shè)備的模型選擇。另外,該科室可以在治療前對(duì)CT成像,從而在照射前確認(rèn)腫瘤的位置,有效避免照射偏離目標(biāo),在MRI引導(dǎo)的放射治療中,也可以實(shí)時(shí)拍攝斷層圖像,根據(jù)情況即時(shí)打開(kāi)和關(guān)閉放射束,避免放療損傷人體正常細(xì)胞。

Tomotherapy|MRIdian(MRI導(dǎo)向放射治療系統(tǒng))

履歷

2005~2006 年,留學(xué)于美國(guó)國(guó)立癌癥研究所

2006 年,完成美國(guó)國(guó)立衛(wèi)生研究所臨床腫瘤學(xué)研究課程

2007 年,日本防衛(wèi)醫(yī)大醫(yī)院放射科講師

2006 年,日本大學(xué)醫(yī)學(xué)部放射科兼任講師

2009 年,東京大學(xué)醫(yī)學(xué)部附屬醫(yī)院放射科非常勤醫(yī)師

2009 年,東京江戶川醫(yī)院放射科部長(zhǎng)

成就

日本醫(yī)學(xué)放射學(xué)會(huì)專家

日本核醫(yī)學(xué)會(huì)專家

日本乳腺癌學(xué)會(huì)乳腺癌專家

日本癌癥治療認(rèn)證醫(yī)療機(jī)構(gòu)癌癥治療認(rèn)證醫(yī)生

認(rèn)證的PET影像醫(yī)生

日本放射腫瘤學(xué)會(huì)認(rèn)證醫(yī)師

日本內(nèi)科醫(yī)學(xué)會(huì)醫(yī)師

日本介入放射學(xué)學(xué)會(huì)醫(yī)師

北美放射學(xué)會(huì)(RSNA)醫(yī)師

美國(guó)癌癥研究協(xié)會(huì)(AACR)醫(yī)師

歐洲放射學(xué)大會(huì)(ECR)醫(yī)師

美國(guó)放射治療與腫瘤學(xué)會(huì)(ASTRO)醫(yī)師

專業(yè)領(lǐng)域

放射腫瘤學(xué),分子成像

部分發(fā)表的學(xué)術(shù)論文

浜幸寛. 放射線治療ビューレイシステムによる新たな癌治療の有用性と経営的貢獻(xiàn) (総特集 放射線治療: 今, 求められる他施設(shè)との差)--(臨床?経営視座での裝置選択?運(yùn)用術(shù))[J]. 月刊新醫(yī)療, 2019, 46(12): 28-31.

浜幸寛. 最新放射線治療の進(jìn)化と普及 民間病院における関東初の BNCT 導(dǎo)入, その経緯並びに臨床的展望[J]. 月刊新醫(yī)療, 2017, 44(6): 68-71.

Naoki Nakamura, Naoto Shikama, Osamu Takahashi, Makiko Ito, Masatoshi Hashimoto, Masahiro Uematsu, Yukihiro Hama, Kenji Sekiguchi, Keiichi Nakagawa. Variability in Bladder Volumes of Full Bladders in Definitive Radiotherapy for Cases of Localized Prostate Cancer

Hama Y, Kaji T. Catheterization-induced injury of the superior vena cava during concurrent chemoradiotherapy. Nihon Univ J Med (in press)

Hama Y, Nakagawa K. Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases. Breast Cancer 2010 (in press)

Hama Y, Iwasaki Y, Kaji T. Selective CT angiography and embolization of the inferior mesenteric artery for massive bladder hemorrhage secondary to locally advanced prostate cancer. Cardiovasc Intervent Radiol (in press : Ms# CVR-2009-0432).

Hamada S, Ito K, Tobe M, Otsuki H, Hama Y, Kato Y, Sugiura Y, Kaji T, Asano T, Hayakawa M. Bilateral adrenal leiomyosarcoma treated with multiple local therapies. Int J Clin Oncol. 2009;14(4):356-60.

Urano Y, Asanuma D, Hama Y, et al. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat Med 2009;15:104-9.

Hama Y. Prone positioning causes the heart to be displaced anteriorly within the thorax: implications for breast cancer treatment. Int J Radiat Oncol Biol Phys 2008;72:302

Longmire MR, Ogawa M, Hama Y, Kosaka N, Regino CA, Choyke PL, Kobayashi H. Determination of optimal rhodamine fluorophore for in vivo optical imaging. Bioconjug Chem 2008;19:1735-42.

Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, Yamamoto M, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol 2008;38:250-8.

Kobayashi S, Kimura F, Hama Y, Ogura K, Torikai H, Kobayashi A, Ikeda T, Sato K, Aida S, Kosuda S, Motoyoshi K. Histiocytic sarcoma of the spleen: case report of asymptomatic onset of thrombocytopenia and complex imaging features. Int J Hematol 2008;87:83-7.

Koyama Y, Barrett T, Hama Y, Ravizzini G, Choyke PL, Kobayashi H. In Vivo Molecular Imaging to Diagnose and Subtype Tumors through Receptor-Targeted Optically Labeled Monoclonal Antibodies. Neoplasia 2007;9:1021-9.

Kobayashi H, Koyama Y, Barrett T, Hama Y, Regino CA, Shin IS, Jang B, Le N, Paik CH, Choyke PL, Urano Y. Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. ACS Nano 2007;1:258-64.

Barrett T, Koyama Y, Hama Y, Ravizzini G, Shin IS, Jang BS, Paik CH, Urano Y, Choyke PL, Kobayashi H. In vivo Diagnosis of Epidermal Growth Factor Receptor Expression using Molecular Imaging with a Cocktail of Optically Labeled Monoclonal Antibodies. Clin Cancer Res 2007;13:6639-48.

Hama Y, Urano Y, Koyama Y, Gunn AJ, Choyke PL, Kobayashi H. A Self-Quenched Galactosamine-Serum Albumin-RhodamineX Conjugate: A "Smart" Fluorescent Molecular Imaging Probe Synthesized with Clinically Applicable Material for Detecting Peritoneal Ovarian Cancer Metastases. Clin Cancer Res 2007;13:6335-43.

Gunn AJ, Hama Y, Koyama Y, Kohn EC, Choyke PL, Kobayashi H. Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore. Cancer Sci 2007;98:1727-33.

Xu H, Regino CA, Koyama Y, Hama Y, Gunn AJ, Bernardo M, Kobayashi H, Choyke PL, Brechbiel MW. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug Chem 2007;18:1474-82.

Hama Y, Matsumoto K, Murugesan R, Subramanian S, Devasahayam N, Koscielniak JW, Hyodo F, Cook JA, Mitchell JB, Krishna MC. Continuous wave EPR oximetric imaging at 300 MHz using radiofrequency power saturation effects. Antioxid Redox Signal 2007;9:1709-16.

Hama Y. Inferior vena cava duplication and left renal aplasia: incidental findings? Br J Radiol. 2007;80(953):e88-92.

Kobayashi H, Hama Y, Koyama Y, Barrett T, Regino CA, Urano Y, Choyke PL. Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett 2007;7:1711-6.

Hama Y, Koyama Y, Choyke PL, Kobayashi H. Two-color in vivo dynamic contrast-enhanced pharmacokinetic imaging. J Biomed Opt 2007;12:034016.

Hama Y, Koyama Y, Urano Y, Choyke PL, Kobayashi H. Two-color lymphatic mapping using Ig-conjugated near infrared optical probes. J Invest Dermatol 2007;127:2351-6.

Hama Y, Koyama Y, Bernardo M, Choyke PL, Kobayashi H. Spectral near-infrared fluorescence imaging of curved surfaces using projection reconstruction algorithms. Contrast Media Mol Imaging 2007;2:82-7.

Hama Y, Uematsu M, Ichikura T, Tamura E, Aida S, Kohno M, Kusano S. A case of primary small cell carcinoma of the cervical esophagus with long-term survival following concurrent chemoradiotherapy: case report and review of the literature. Tumori 1999;85:284-7.

免責(zé)聲明:本公司力求為用戶提供準(zhǔn)確、客觀的信息資料與數(shù)據(jù),公司所提供的信息均來(lái)源于網(wǎng)絡(luò)上公開(kāi)發(fā)表的文獻(xiàn)或文章,僅供用戶參考使用,用戶據(jù)此作出的選擇和判斷,公司不承擔(dān)任何經(jīng)濟(jì)與法律責(zé)任。

全球咨詢服務(wù)熱線

400-086-8008

English | 微信端

互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號(hào):(京)·非經(jīng)營(yíng)性·2015·0179
厚樸方舟健康管理(北京)有限公司 版權(quán)所有 www.qekelqr.cn 京ICP備15061794號(hào) 京公網(wǎng)安備 11010502027115號(hào)